Literature DB >> 23279510

Testicular steroids, prolactin, relaxin and prostate gland markers in peripheral blood and seminal plasma of normal dogs and dogs with prostatic hyperplasia.

K Wolf1, H Kayacelebi, C Urhausen, M Piechotta, R Mischke, S Kramer, A Einspanier, C H Y Oei, A Günzel-Apel.   

Abstract

Concentrations of 17β-oestradiol (E(2) ), testosterone (T), 5α-dihydrotestosterone, prolactin (PRL) and relaxin (RLN) were determined in peripheral blood serum or plasma and prostatic secretion of 77 physically healthy intact male dogs (19 Rhodesian Ridgebacks/RR, 58 dogs of other breeds, 1-9 years of age). Furthermore, the concentrations of acid phosphatase in prostatic secretion and canine prostate-specific esterase (CPSE) were measured in blood plasma. All dogs were submitted to a complete breeding soundness examination, including B-mode sonography. Prostatic volume was larger, and blood plasma levels of CPSE were higher in ageing dogs and in dogs with benign prostatic hyperplasia (BPH) compared with young dogs and dogs with normal prostate. Furthermore, a higher E(2) /T ratio was found in dogs with BPH. Despite missing significant differences in PRL concentrations, the slight increases in PRL concentrations in the prostatic secretion observed both with increasing age and in dogs with BPH and the observed correlations between concentrations of PRL and testicular steroids may possibly indicate a role of PRL in the pathogenesis of canine BPH. Serum RLN concentrations were at similar level in all dogs. Regarding breed differences, an appreciably larger prostatic volume and higher concentration of CPSE were verified in RR than in other pure-bred dogs, confirming our suspicion of a premature enlargement of the prostate gland, which may result from a genetic disposition for BPH in this breed.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279510     DOI: 10.1111/rda.12083

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  7 in total

1.  Does finasteride treatment for benign prostatic hyperplasia influence sperm DNA integrity in dogs?

Authors:  Daniel S R Angrimani; Luana C Bicudo; Nuria Llamas Luceño; Bruno R Rui; Matheus F Silva; João D A Losano; Bart Leemans; Ann Van Soom; Camila I Vannucchi
Journal:  Basic Clin Androl       Date:  2020-07-16

2.  Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia.

Authors:  Dora Pinheiro; João Machado; Carlos Viegas; Cláudia Baptista; Estela Bastos; Joana Magalhães; Maria A Pires; Luís Cardoso; Ana Martins-Bessa
Journal:  BMC Vet Res       Date:  2017-03-23       Impact factor: 2.741

3.  Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy.

Authors:  Daniel S R Angrimani; Maria Claudia P Francischini; Maíra M Brito; Camila I Vannucchi
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

4.  Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.

Authors:  Daniel S R Angrimani; Maíra M Brito; Bruno R Rui; Marcílio Nichi; Camila I Vannucchi
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

Review 5.  Highlights on the Canine Prostatic Specific Esterase (CPSE): A diagnostic and screening tool in veterinary andrology.

Authors:  Monica Melandri; Salvatore Alonge
Journal:  Vet Med Sci       Date:  2020-09-02

6.  Concentrations of canine prostate specific esterase, CPSE, at baseline are associated with the relative size of the prostate at three-year follow-up.

Authors:  Bodil S Holst; Sofia Carlin; Virginie Fouriez-Lablée; Sofia Hanås; Sofie Ödling; Liss-Marie Langborg; S J Kumari A Ubhayasekera; Jonas Bergquist; Jesper Rydén; Elin Holmroos; Kerstin Hansson
Journal:  BMC Vet Res       Date:  2021-04-26       Impact factor: 2.741

Review 7.  Comparative pathology of dog and human prostate cancer.

Authors:  Toby Ryman-Tubb; Jennifer H Lothion-Roy; Veronika M Metzler; Anna E Harris; Brian D Robinson; Albert A Rizvanov; Jennie N Jeyapalan; Victoria H James; Gary England; Catrin S Rutland; Jenny L Persson; Lukas Kenner; Mark A Rubin; Nigel P Mongan; Simone de Brot
Journal:  Vet Med Sci       Date:  2021-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.